Skip to main content
All lobbying filings

Exact Sciences

Exact Sciences filed a Q1 termination report for Exact Sciences on April 20, 2026.

Lobbying for Exact Sciences · cancer diagnostic company

As filed: EXACT SCIENCES for EXACT SCIENCES.

All filings by Exact Sciences · Everything Exact Sciences has reported

 Filing · LD-2 quarterly report Q1 termination
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Expenses
$400,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Wisconsin
Representation ended
Mar 23, 2026
The registrant reported terminating its work for this client.

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

HR 842/S 339 support Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act H.R. 7118 support Genomic Answers for Childrens Health Act Support colorectal cancer screening prevention standards

Support patient access to cancer screening and diagnostics

Support veteran access to guideline-recommended colorectal cancer screening

 Bills named in this filing 2
  • H.R. 842
    Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
  • H.R. 7118
    Genomic Answers for Children’s Health Act of 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem